Finally, a small prospective study conducted on eight advanced HCC patients demonstrated that response to anti-PD-1 therapy was associated with the presence of A. muciniphila and various Ruminococcaceae species in stool samples, while non-responder patients exhibited increased microbial dissimilarity [64]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.